Search Results - Endovascular Today

Sponsored by Boston Scientific Corporation

evt | Article | October 2017 Supplement

Yttrium-90 Segmentectomy Flow Diversion Using Embozene™ Microspheres

By Paul O'Connor, MD; Aaron M. Fischman, MD; and Edward Kim, MD; Mount Sinai Health System

evt | News | July 22, 2024

Rapid Medical’s Drivewire 24 Platform Used in Initial Neurovascular Procedures

July 22, 2024—Rapid Medical announced that the first commercial cases in the United States were conducted with the company’s Drivewire 24 deflectable access platform after receiving FDA clearance for the device.

evt | Article | November 2017

Ask the Experts: What Is Your Protocol for Following Patients After TEVAR?

Expects comment on their approach to surveillance for patients with aneurysmal disease versus aortic dissection.

With Rajesh K. Malik, MD, FACS, RPVI; Tilo Kölbel, MD, PhD; Patrick Kelly, MD; and James F. McKinsey, MD

evt | Article | January 2026

Next-Generation PERT Concepts: Ensuring Sustainability While Improving Care Pathways

Moderator Kenneth Rosenfield, MD, MHCDS, leads an expert conversation on sustaining PERT programs, preventing burnout, reducing therapeutic bias, integrating AI, and improving patient-centered PE care.

With moderator Kenneth Rosenfield, MD, MHCDS; Vivian L. Bishay, MD; Patrick Muck, MD, and Sameh Sayfo, MD, MBA, FSCAI, FACC

evt | Article | July 2020

Venous and Arterial Thrombus Removal With the Indigo System: Pulmonary Embolism Indication

With Robert A. Lookstein, MD, MHCDL, FSIR, FAHA, FSVM; José A. Guirola, MD, PhD, EBIR; Miguel A. de Gregorio, PhD, EBIR, FSIR, FCIRSE; Andrew Gemmell, MBChB, FRCR; Juan José Ciampi-Dopazo, MD, EBIR; Pedro Pardo Moreno, MD, PhD; Gonzalo Ruiz Villaverde, MD, PhD; AbdulRahman Alvi, MRCS, FRCR; Francesco Intrieri, MD; Vincenzo Molinari, MD; and Heiko Wendorff, MD, FEBVS

Sponsored by Boston Scientific Corporation

evt | Article | May 2019 Supplement

Roundtable Discussion: The Evolution of the CLI Treatment Algorithm

A multidisciplinary panel shares insights on practice patterns, treatment algorithms, and hopes for future solutions for this challenging disease.

With Ralf Langhoff, MD; Robert A. Lookstein, MD; Miguel Montero-Baker, MD; and Jihad A. Mustapha, MD, FACC, FSCAI

evt | News | July 14, 2025

Borvo’s EVAC System Studied to Treat Chronic Subdural Hematoma

July 14, 2025—Borvo Medical, a portfolio company of NeuroTechnology Investors, announced findings for the company’s FDA-cleared endoport vacuum-assisted collection (EVAC) system for the treatment of chronic subdural hematomas (SDHs).

evt | News | July 10, 2025

Radical’s 8-F Neurovascular Guide Catheter Evaluated in Initial Clinical Procedures

July 10, 2025—Radical Catheter Technologies, a NeuroTechnology Investors portfolio company, announced the initial clinical procedures with the 8-F Radical neurovascular guide catheter.

evt | News | August 23, 2022

DIVE Trial of IRRAflow System to Treat Intraventricular Hemorrhage Begins Enrollment

August 23, 2022—IRRAS, a Stockholm, Sweden–based medical technology company focused on neurocritical care, announced the initial patient treatments with the company’s IRRAflow system as part of the company’s DIVE clinical trial.

evt | Article | February 2024

Optimizing Prostatic Artery Embolization Outcomes

Experts discuss the impact of the updated American Urological Association guidelines, current evidence and long-term data, patient candidacy, imaging and embolic selection, the reimbursement landscape, establishing referral relationships, and the next phases of clinical research.

With Tiago Bilhim, MD, PhD, EBIR-ES, FCIRSE, FSIR; Samdeep Mouli, MD, MS; Aaron M. Fischman, MD, FSIR, FCIRSE, FSVM; and Rachel Piechowiak, DO

evt | Article | September 2020

Radial Access for PAD: Can We Get There From Here?

Two radial access experts discuss potential advantages and pitfalls, device availability, and patient candidacy for infrainguinal cases.

With Sabeen Dhand, MD, and Aaron M. Fischman, MD, FSIR, FCIRSE

evt | News | March 9, 2026

Route 92 Begins SUMMIT RISE Postmarket Study of its Neurovascular Interventional Portfolio

March 9, 2026—Route 92 Medical, Inc. announced the commencement of the SUMMIT RISE postmarket study evaluating the performance of the company’s portfolio of neurovascular interventional solutions across a variety of stroke scenarios and vessel sizes.

evt | News | April 27, 2022

AngioDynamics Launches APEX-AV Study in Partnership with PERT Consortium

April 27, 2022—AngioDynamics, Inc. announced the launch of APEX-AV, the “Acute Pulmonary Embolism Extraction Trial with the AlphaVac System” clinical study, which is aimed at evaluating the efficacy and safety of the company’s AlphaVac multipurpose mechanical aspiration (MMA) F1885 system in the treatment of acute intermediate-risk pulmonary embolism (PE).

evt | News | July 22, 2024

Radical Catheter Technologies 7-F Radical Neurovascular Catheter Receives FDA Clearance

July 22, 2024—Radical Catheter Technologies, a medical device company developing endovascular access and delivery products, announced FDA 510(k) clearance for the Radical catheter.

evt | Article | April 2026

Achieving Excellence Across Embolization Applications

Experience at a large, urban academic institution with a focus on comprehensive clinical practice, multidisciplinary collaboration, innovation, and training.

By Ariana Mills, MD; Bryan Pacheco, MD; Linzi Webster, MD, MBA; Rahul Patel, MD, FSIR; Kirema Garcia-Reyes, MD; and Aaron Fischman, MD, FSIR

evt | News | October 3, 2024

Synchron’s Brain-Computer Interface Evaluated in COMMAND Early Feasibility Study

October 3, 2024—Synchron recently announced positive results from the COMMAND early feasibility study, which is evaluating the safety and efficacy of the Synchron brain computer interface (BCI, called the Stentrode) in six patients over a 12-month period.

evt | News | March 26, 2024

SIR Names Dr. Robert J. Lewandowski as President for 2024-2025

March 26, 2024—The Society of Interventional Radiology (SIR) announced that Robert J. Lewandowski, MD, assumed the office of president of the society for the 2024-2025 term. Dr. Lewandowski is an interventional radiologist (IR) and professor at Northwestern Medicine Feinberg School of Medicine in Chicago, Illinois.

Sponsored by Boston Scientific Corporation

evt | Article | January 2016 Supplement

Endovascular Management of Deep Vein Thrombosis: An Expert Panel Discussion

Endovascular Today met with a multidisciplinary panel of venous experts to discuss the current status of DVT treatment in the United States and abroad and how the field has evolved in the last 10 years.

With Mark Garcia, MD, MS, FSIR; Nils Kucher, MD; Robert A. Lookstein, MD; Gerard O'Sullivan, MD; and Jeffrey Y. Wang, MD

evt | News | September 5, 2023

Synchron’s COMMAND Early Feasibility Study of Brain-Computer Interface Completes Enrollment

September 5, 2023—Synchron, an endovascular brain-computer interface (BCI) company developing implantable neural interface technology to restore functionality in patients with severe paralysis, announced completion of patient enrollment in the United States-based COMMAND early feasibility study (EFS).

evt | News | June 9, 2021

Cerenovus’ TruFill n-BCA Liquid Embolic System Evaluated for Treatment of Chronic Subdural Hematoma

June 9, 2021—Cerenovus, a Johnson & Johnson Medical Devices Companies, announced that the first patient has been enrolled in the company-sponsored MEMBRANE study evaluating the safety and efficacy of its investigational TruFill n-Butyl cyanoacrylate liquid embolic system in the embolization of the middle meningeal artery (MMA) for treatment of chronic subdural hematoma (cSDH) as adjunct to surgical evacuation or as a stand-alone treatment.